| 0.4 |
1.3 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.4 |
1.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.3 |
1.4 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.3 |
0.8 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.3 |
0.8 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.3 |
1.5 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.3 |
1.0 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.3 |
1.5 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
0.7 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.2 |
0.9 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
1.1 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
| 0.2 |
0.7 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 0.2 |
0.9 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.2 |
0.9 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 |
0.2 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.2 |
0.2 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.2 |
0.8 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.2 |
0.4 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.2 |
0.6 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.2 |
0.6 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 |
0.6 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.2 |
1.1 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 |
0.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 |
0.9 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.2 |
0.2 |
GO:0009946 |
proximal/distal axis specification(GO:0009946) |
| 0.2 |
0.4 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 |
0.5 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.2 |
0.5 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.2 |
0.7 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.2 |
1.2 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.2 |
0.5 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.2 |
0.9 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.2 |
0.5 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 |
0.5 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 0.2 |
0.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 |
0.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.2 |
0.8 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.2 |
0.8 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.2 |
0.8 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.2 |
0.5 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.2 |
0.5 |
GO:0046959 |
habituation(GO:0046959) |
| 0.2 |
0.6 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.2 |
0.8 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.2 |
0.5 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.2 |
0.5 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.2 |
0.8 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.2 |
0.6 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 |
0.5 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.2 |
0.9 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.9 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
0.7 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.1 |
0.7 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.1 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.1 |
0.4 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.1 |
0.4 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.1 |
0.6 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 0.1 |
0.4 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
0.4 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.1 |
0.7 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.1 |
0.9 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.1 |
0.9 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.7 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 0.1 |
0.1 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 |
0.3 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 0.1 |
0.1 |
GO:0071864 |
positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.1 |
0.4 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.3 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 |
0.1 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 |
0.4 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.1 |
0.5 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.1 |
0.1 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.1 |
0.1 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.1 |
0.6 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
0.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 |
0.5 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.1 |
0.5 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.1 |
0.5 |
GO:2000256 |
positive regulation of male germ cell proliferation(GO:2000256) |
| 0.1 |
0.1 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.1 |
1.4 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.4 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 |
0.8 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
0.4 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.4 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.1 |
0.5 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 |
0.4 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.8 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 |
1.7 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.3 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.2 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 |
0.8 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.1 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.1 |
0.3 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.1 |
0.5 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 |
0.2 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 |
0.3 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 0.1 |
0.8 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.1 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) |
| 0.1 |
0.4 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.1 |
0.5 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
0.5 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.1 |
0.3 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.1 |
0.4 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 |
1.0 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.1 |
0.2 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.1 |
0.1 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.1 |
0.1 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.1 |
0.7 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.1 |
0.4 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.1 |
0.9 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.1 |
0.3 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.1 |
0.3 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 |
0.1 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
0.1 |
GO:0039519 |
modulation by virus of host autophagy(GO:0039519) |
| 0.1 |
1.0 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
1.1 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.1 |
0.7 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
0.5 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.3 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
1.4 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.1 |
0.3 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
0.3 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.1 |
0.2 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.1 |
0.4 |
GO:0061626 |
pharyngeal arch artery morphogenesis(GO:0061626) |
| 0.1 |
0.5 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.1 |
1.6 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.4 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.5 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.5 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.3 |
GO:1905154 |
negative regulation of membrane invagination(GO:1905154) |
| 0.1 |
0.1 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.1 |
0.1 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.1 |
0.1 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.1 |
0.4 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.1 |
0.2 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.3 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.1 |
0.5 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.1 |
0.3 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.1 |
0.1 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.1 |
1.8 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
0.6 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.2 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 |
0.1 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.1 |
0.5 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
0.2 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.1 |
0.5 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 |
0.4 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 |
0.2 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.1 |
0.8 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.2 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 |
0.3 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 0.1 |
0.2 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.1 |
0.4 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) |
| 0.1 |
0.3 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 0.1 |
0.3 |
GO:0070922 |
small RNA loading onto RISC(GO:0070922) |
| 0.1 |
0.3 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
| 0.1 |
0.5 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.1 |
0.3 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 0.1 |
0.4 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 0.1 |
0.1 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.1 |
0.2 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.9 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
1.0 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.1 |
0.3 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.1 |
0.2 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.1 |
0.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.2 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 |
0.6 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.1 |
0.2 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.4 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.1 |
0.9 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 |
0.4 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.1 |
1.0 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
0.2 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
0.4 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 |
0.2 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.1 |
0.3 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.1 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
0.2 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.2 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
1.1 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.2 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.1 |
0.6 |
GO:0098828 |
modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
0.1 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.1 |
0.1 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.1 |
0.2 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.1 |
0.5 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.1 |
0.2 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.1 |
0.2 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.2 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.9 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.6 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.4 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 |
0.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.2 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.1 |
0.1 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
0.3 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.1 |
0.3 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.3 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.1 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 |
0.4 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.1 |
0.5 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.4 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.1 |
0.1 |
GO:1905207 |
regulation of cardiocyte differentiation(GO:1905207) |
| 0.1 |
0.4 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.5 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.1 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.1 |
0.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
1.4 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
1.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
0.3 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.1 |
0.3 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
1.6 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 |
0.2 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.1 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
0.4 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.1 |
0.6 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.2 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 |
0.4 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.1 |
0.2 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.1 |
0.3 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.1 |
0.7 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.3 |
GO:0060709 |
glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.1 |
0.3 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
1.4 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 |
0.2 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.5 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.3 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.1 |
0.1 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.3 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.3 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
0.3 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.1 |
0.6 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
0.1 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.1 |
0.1 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 |
0.4 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.1 |
0.1 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.1 |
0.5 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
0.5 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.1 |
0.1 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 |
1.2 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 |
0.6 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.1 |
GO:0071335 |
hair follicle cell proliferation(GO:0071335) |
| 0.1 |
0.3 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.1 |
0.3 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
1.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.1 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.1 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.2 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 |
0.2 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.2 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.1 |
0.3 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
0.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.1 |
0.4 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.1 |
0.2 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.1 |
0.1 |
GO:0044332 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.1 |
0.3 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.5 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.2 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.1 |
0.5 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.1 |
0.3 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
0.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.1 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.1 |
0.1 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.1 |
0.1 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.1 |
0.3 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.1 |
0.5 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.1 |
0.1 |
GO:2000642 |
negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 |
0.1 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.1 |
0.2 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.1 |
0.2 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.1 |
0.4 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.1 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.1 |
0.4 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
0.2 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.1 |
0.5 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 0.1 |
0.1 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.1 |
0.6 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.1 |
1.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.6 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.3 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.2 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.1 |
0.1 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.1 |
0.1 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.1 |
0.5 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.3 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.1 |
0.2 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) |
| 0.1 |
0.2 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
0.3 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.1 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.1 |
0.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.1 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 |
0.1 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 |
0.1 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.1 |
0.1 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.1 |
0.1 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.1 |
0.2 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.2 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.1 |
0.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.1 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.5 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.1 |
0.1 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.1 |
0.2 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.1 |
GO:0048546 |
digestive tract morphogenesis(GO:0048546) |
| 0.1 |
0.7 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.4 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
0.2 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.1 |
1.5 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
0.2 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
0.2 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.1 |
0.1 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.1 |
0.1 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
0.1 |
GO:0090427 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) activation of meiosis(GO:0090427) |
| 0.1 |
0.5 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.1 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.6 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.5 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.6 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.2 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.1 |
0.2 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.1 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.2 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.3 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
0.1 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.1 |
0.2 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.4 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.4 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.1 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 |
0.1 |
GO:0016553 |
base conversion or substitution editing(GO:0016553) |
| 0.1 |
0.1 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.2 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.3 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.1 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
0.2 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.1 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.1 |
0.2 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.2 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
0.9 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.3 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.1 |
0.1 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.1 |
0.2 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.1 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.0 |
0.0 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.0 |
0.1 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.0 |
0.1 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.0 |
0.1 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.0 |
0.3 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.0 |
0.1 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.0 |
0.1 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.0 |
0.2 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.0 |
0.0 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.0 |
0.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.5 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.2 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.0 |
0.1 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.0 |
0.0 |
GO:1903147 |
negative regulation of mitophagy(GO:1903147) |
| 0.0 |
0.3 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.0 |
0.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.2 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.0 |
0.4 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.5 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.2 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.0 |
0.0 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.0 |
0.0 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.0 |
0.1 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.0 |
0.1 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.0 |
0.2 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.0 |
0.4 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.0 |
0.1 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.0 |
0.2 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.0 |
0.1 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.0 |
0.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.0 |
0.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.4 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.0 |
0.1 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.0 |
0.2 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.0 |
0.8 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.1 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.0 |
0.0 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.0 |
0.0 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 |
0.0 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.0 |
0.4 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 |
0.0 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 |
0.0 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.0 |
0.1 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.0 |
0.3 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.0 |
0.3 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 |
0.4 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.0 |
0.1 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.0 |
0.0 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.0 |
0.5 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.0 |
GO:2000484 |
positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.0 |
0.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.3 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.0 |
0.8 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.0 |
0.4 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.2 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.0 |
0.1 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.0 |
0.2 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 |
0.2 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.0 |
0.1 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.1 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 |
0.1 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.0 |
0.5 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.0 |
0.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.2 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.0 |
0.0 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.0 |
0.4 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.0 |
0.1 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.0 |
0.1 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.0 |
0.3 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.0 |
0.1 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.6 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.0 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.0 |
0.3 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.0 |
0.2 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.0 |
1.0 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
0.2 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.0 |
0.2 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.0 |
0.3 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.0 |
0.0 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.0 |
0.5 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.0 |
0.0 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.0 |
0.1 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.0 |
0.2 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.0 |
0.1 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.2 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.4 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 |
0.2 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 |
0.3 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.2 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.0 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.2 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.0 |
0.1 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.0 |
0.4 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.1 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.0 |
0.1 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.2 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.0 |
0.3 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.0 |
0.1 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.0 |
0.1 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.0 |
0.1 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.0 |
0.2 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.0 |
0.0 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.0 |
0.2 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.9 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 |
0.5 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.3 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 |
0.5 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.0 |
GO:0090239 |
regulation of histone H4 acetylation(GO:0090239) |
| 0.0 |
0.0 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.0 |
0.0 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.0 |
0.2 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.3 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
1.1 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.3 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 |
0.4 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.2 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 |
0.1 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.0 |
0.1 |
GO:0048669 |
collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.0 |
0.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.2 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.0 |
0.1 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 |
0.1 |
GO:0045852 |
pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.0 |
0.1 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.0 |
0.1 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.0 |
0.1 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.0 |
0.1 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.0 |
0.1 |
GO:0090179 |
planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.0 |
0.0 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.0 |
0.1 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.0 |
0.1 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.0 |
0.1 |
GO:0046618 |
drug export(GO:0046618) |
| 0.0 |
0.6 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.0 |
0.1 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.0 |
0.3 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.1 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.0 |
0.1 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.0 |
0.1 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.0 |
0.5 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.4 |
GO:0070613 |
regulation of protein processing(GO:0070613) |
| 0.0 |
0.0 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.0 |
0.1 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.0 |
2.4 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.0 |
0.1 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.0 |
0.3 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.1 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.0 |
0.1 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.0 |
0.0 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.0 |
0.2 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.0 |
0.5 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.0 |
0.2 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.0 |
0.2 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.0 |
0.5 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.1 |
GO:0050965 |
sensory perception of temperature stimulus(GO:0050951) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.0 |
0.1 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.0 |
0.8 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.1 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.0 |
0.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.1 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 |
0.6 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.0 |
0.4 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.0 |
0.1 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.1 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.0 |
0.4 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
| 0.0 |
0.1 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.0 |
0.2 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.0 |
0.1 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.0 |
0.1 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.0 |
0.1 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.0 |
0.1 |
GO:0035066 |
positive regulation of histone acetylation(GO:0035066) |
| 0.0 |
0.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.0 |
0.2 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.0 |
0.1 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) positive regulation of neurotransmitter transport(GO:0051590) |
| 0.0 |
0.2 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
0.1 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.0 |
0.1 |
GO:2000768 |
glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.0 |
0.1 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
0.1 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.0 |
0.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.1 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) response to cycloheximide(GO:0046898) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.0 |
0.3 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.0 |
0.1 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.0 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.0 |
0.2 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
0.2 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 |
0.0 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.0 |
0.1 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
0.0 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.0 |
0.1 |
GO:0090178 |
regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
| 0.0 |
0.1 |
GO:1902965 |
protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.0 |
0.1 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.0 |
0.0 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.0 |
0.3 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.0 |
0.2 |
GO:0035247 |
peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.0 |
0.1 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.0 |
2.4 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.1 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.1 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.0 |
0.1 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.0 |
0.0 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.0 |
0.1 |
GO:1903020 |
positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.0 |
0.2 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.0 |
0.7 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.0 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.0 |
0.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.1 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.0 |
0.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 |
0.4 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.2 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.0 |
0.7 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.1 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.0 |
0.0 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.1 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.0 |
0.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.0 |
0.3 |
GO:1901978 |
positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.0 |
0.1 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 |
0.3 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.0 |
0.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.2 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 |
0.1 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.0 |
0.0 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.3 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.1 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
0.2 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.0 |
0.1 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.0 |
0.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.0 |
0.0 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
| 0.0 |
0.2 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.0 |
0.1 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.0 |
0.2 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.0 |
0.0 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.0 |
0.1 |
GO:1902861 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) copper ion import into cell(GO:1902861) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.1 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 |
0.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.0 |
0.1 |
GO:0003011 |
involuntary skeletal muscle contraction(GO:0003011) |
| 0.0 |
0.1 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.0 |
0.0 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.0 |
0.0 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.0 |
0.1 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.0 |
0.1 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.0 |
0.5 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.1 |
GO:0032512 |
regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.0 |
0.1 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.0 |
0.6 |
GO:0044819 |
mitotic G1/S transition checkpoint(GO:0044819) |
| 0.0 |
0.0 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.0 |
0.3 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.0 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.0 |
0.1 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.0 |
0.4 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.0 |
0.1 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.1 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.0 |
0.1 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.2 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.0 |
0.1 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 |
0.0 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.0 |
0.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.0 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.0 |
0.6 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.1 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 |
0.2 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.1 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.0 |
0.1 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.0 |
0.1 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.0 |
0.1 |
GO:0070669 |
response to interleukin-2(GO:0070669) |
| 0.0 |
0.1 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.0 |
0.1 |
GO:0060412 |
ventricular septum morphogenesis(GO:0060412) |
| 0.0 |
0.1 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.0 |
0.2 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 |
0.0 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.0 |
0.1 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.0 |
0.1 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.0 |
0.1 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.0 |
0.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.1 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.0 |
0.2 |
GO:2000479 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.0 |
0.1 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.0 |
0.1 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.0 |
0.1 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.0 |
0.1 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.0 |
0.1 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 |
0.1 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.0 |
0.2 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.1 |
GO:0032308 |
positive regulation of prostaglandin secretion(GO:0032308) |
| 0.0 |
0.1 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.0 |
0.9 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.1 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.0 |
0.1 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.0 |
0.1 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.0 |
0.1 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.0 |
0.0 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 |
0.2 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.0 |
GO:0045040 |
outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 |
0.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.0 |
0.0 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.0 |
0.0 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.1 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of receptor catabolic process(GO:2000645) |
| 0.0 |
0.1 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.0 |
0.1 |
GO:0048617 |
embryonic foregut morphogenesis(GO:0048617) |
| 0.0 |
0.0 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.0 |
0.0 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.0 |
0.1 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.0 |
0.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.0 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.0 |
0.2 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.0 |
0.2 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.0 |
0.0 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.1 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.0 |
0.0 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 |
0.1 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.1 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.0 |
0.2 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.0 |
0.0 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 |
0.1 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.4 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.1 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.0 |
0.1 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.2 |
GO:0061339 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.0 |
0.1 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.0 |
0.2 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.1 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 |
0.0 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.0 |
0.1 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
1.0 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.1 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.1 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
0.1 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 |
0.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.0 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
0.0 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.0 |
0.1 |
GO:0051883 |
disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
| 0.0 |
0.0 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.2 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 |
0.0 |
GO:0061620 |
glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.0 |
0.1 |
GO:0021681 |
cerebellar granular layer development(GO:0021681) |
| 0.0 |
0.1 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.0 |
0.0 |
GO:0051798 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.0 |
0.0 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.0 |
0.0 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.0 |
0.1 |
GO:1902044 |
regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
| 0.0 |
0.0 |
GO:1903977 |
positive regulation of glial cell migration(GO:1903977) |
| 0.0 |
0.4 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.0 |
0.1 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.0 |
0.1 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 |
0.1 |
GO:0009988 |
binding of sperm to zona pellucida(GO:0007339) cell-cell recognition(GO:0009988) sperm-egg recognition(GO:0035036) |
| 0.0 |
0.0 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 |
0.0 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.3 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.1 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.0 |
0.1 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.0 |
0.0 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.1 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.0 |
0.2 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.0 |
0.1 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.1 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) respiratory burst involved in defense response(GO:0002679) |
| 0.0 |
0.1 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.0 |
0.0 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.0 |
0.1 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.0 |
0.2 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 |
0.3 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.1 |
GO:0046602 |
mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 |
0.1 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 |
0.1 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
0.1 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.0 |
GO:0032070 |
regulation of deoxyribonuclease activity(GO:0032070) |
| 0.0 |
0.1 |
GO:0045932 |
negative regulation of muscle contraction(GO:0045932) |
| 0.0 |
0.0 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 |
0.2 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.0 |
0.0 |
GO:1905206 |
positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.0 |
0.1 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.0 |
0.1 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.0 |
0.0 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.0 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 0.0 |
0.1 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.4 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.0 |
0.4 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.1 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.0 |
0.0 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.0 |
0.0 |
GO:0010823 |
negative regulation of mitochondrion organization(GO:0010823) |
| 0.0 |
0.0 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.0 |
0.3 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.0 |
0.1 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.1 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.0 |
0.2 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.1 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.0 |
0.1 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.0 |
0.1 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 |
0.1 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.0 |
0.1 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.0 |
0.1 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 |
0.1 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.0 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.3 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.1 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.1 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.0 |
0.0 |
GO:0033865 |
nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.0 |
0.1 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.0 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.0 |
0.2 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.1 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.2 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
0.1 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.0 |
0.5 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
0.1 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.1 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.0 |
0.0 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.0 |
0.1 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.0 |
0.0 |
GO:0030071 |
regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.0 |
0.0 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.0 |
0.0 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.0 |
0.1 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 |
0.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.0 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.0 |
0.1 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.0 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.0 |
0.0 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 0.0 |
0.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.0 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.0 |
0.1 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.0 |
0.1 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.0 |
0.1 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 |
0.2 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.0 |
0.1 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.2 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.0 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.1 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.0 |
0.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.0 |
0.1 |
GO:0046416 |
D-amino acid catabolic process(GO:0019478) D-amino acid metabolic process(GO:0046416) |
| 0.0 |
0.1 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.0 |
0.3 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.0 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.0 |
0.1 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.0 |
0.1 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.0 |
0.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.0 |
0.1 |
GO:0070827 |
chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.0 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.0 |
0.1 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 |
0.1 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.0 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.0 |
0.0 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.0 |
0.1 |
GO:0090086 |
regulation of protein deubiquitination(GO:0090085) negative regulation of protein deubiquitination(GO:0090086) |
| 0.0 |
0.0 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.0 |
0.0 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 |
0.1 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.0 |
0.0 |
GO:0046398 |
UDP-glucuronate metabolic process(GO:0046398) |
| 0.0 |
0.0 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 |
0.0 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.0 |
0.0 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.0 |
0.2 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.0 |
0.0 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.0 |
0.1 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.0 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.0 |
0.5 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.1 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.0 |
0.2 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.1 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.0 |
0.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.0 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.0 |
0.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.0 |
GO:0048261 |
negative regulation of receptor-mediated endocytosis(GO:0048261) |
| 0.0 |
0.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.0 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.0 |
0.0 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.0 |
0.0 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.0 |
GO:0009186 |
deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.0 |
0.2 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.0 |
0.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.1 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.0 |
0.0 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.0 |
0.0 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.0 |
GO:0061245 |
establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
| 0.0 |
0.2 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
0.3 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.0 |
0.0 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.0 |
0.2 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.0 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.0 |
0.0 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
| 0.0 |
0.0 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.0 |
0.1 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.1 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 |
0.0 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 |
0.0 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.0 |
0.0 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.2 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.1 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.1 |
GO:0034183 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.0 |
1.6 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.1 |
GO:0051154 |
negative regulation of striated muscle cell differentiation(GO:0051154) |
| 0.0 |
0.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.0 |
GO:1902683 |
regulation of protein localization to synapse(GO:1902473) regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.3 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.0 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.0 |
0.0 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
0.1 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.1 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.0 |
0.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.0 |
0.1 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.0 |
0.4 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.0 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.0 |
0.2 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.0 |
0.0 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 |
0.0 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
0.2 |
GO:0006278 |
RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.3 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.0 |
0.0 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.0 |
0.1 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.0 |
0.0 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.0 |
0.1 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.0 |
0.0 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
| 0.0 |
0.0 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.0 |
0.1 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.0 |
0.1 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.1 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 |
0.0 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.0 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.0 |
0.0 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.0 |
0.0 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 |
0.0 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.0 |
0.0 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.0 |
0.0 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.0 |
0.2 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.0 |
0.1 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.0 |
0.1 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.0 |
0.1 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.0 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.0 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.1 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.2 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.0 |
0.0 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.0 |
0.1 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 |
0.0 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.1 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
0.1 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.0 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.0 |
0.0 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.0 |
0.1 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.0 |
0.0 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 |
0.0 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.0 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.0 |
0.0 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.1 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.0 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.0 |
0.0 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.0 |
0.1 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.3 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.1 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.0 |
0.0 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.0 |
0.1 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.0 |
0.1 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.2 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.0 |
0.0 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.0 |
0.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
0.0 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
0.0 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.0 |
0.1 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 |
0.0 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.0 |
0.2 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.1 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 |
0.0 |
GO:0051340 |
regulation of ligase activity(GO:0051340) |
| 0.0 |
0.1 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 |
0.1 |
GO:0043173 |
nucleotide salvage(GO:0043173) |
| 0.0 |
0.1 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.2 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.0 |
0.0 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.1 |
GO:0061097 |
regulation of protein tyrosine kinase activity(GO:0061097) |
| 0.0 |
0.1 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.2 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 |
0.0 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.0 |
0.0 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
